Biochemical recurrence prediction on Internal cohort (test)
-0.36Coefficient BetaPathological T stage
Evaluation results
| Method | Links | |||||
|---|---|---|---|---|---|---|
| Pathological T stagestage=2b2026.03 | -0.36 | 0.7 | 0.13 | 0.672 | — | |
| Pathological T stagestage=2c2026.03 | -0.12 | 0.89 | 0.73 | 0.252 | — | |
| Positive Lymph Node Count2026.03 | -0.002 | 1 | 0.75 | 0.987 | — | |
| Age2026.03 | 0.001 | 1 | 0.99 | 0.86 | — | |
| Tumor Percentage2026.03 | 0.003 | 1 | 1 | 0.124 | — | |
| Preoperative PSA2026.03 | 0.01 | 1.01 | 1 | 0.009 | — | |
| Pathological T stagestage=3a2026.03 | 0.02 | 1.02 | 0.81 | 0.88 | — | |
| Pathological Gleason Score2026.03 | 0.14 | 1.16 | 1.02 | 0.025 | — | |
| Pathological T stagestage=42026.03 | 0.14 | 1.15 | 0.46 | 0.763 | — | |
| Lymphatic Invasion2026.03 | 0.22 | 1.25 | 0.97 | 0.091 | — | |
| Pathological T stagestage=3b2026.03 | 0.25 | 1.28 | 1 | 0.05 | — | |
| Surgical Margin Status2026.03 | 0.26 | 1.3 | 1.07 | 0.009 | — | |
| AI Risk ScoreModel=Multivariable Cox Proportional Hazards Analysis2026.03 | 1.38 | 3.97 | 2.68 | 0.001 | 79 |